Skip to main content

Find Clinical Trials

Home
Conditions
Cytopenia

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

1,007 public trials 191 recruiting studies

Refine in advanced search Browse all conditions

Cytopenia trial results

Completed

Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

NCT02604420

Conditions: Blood Platelet Disorders, Cytopenia, Disorder Related to Bone Marrow Transplantation, +5 more
Locations: New York Presbyterian Hospital New York, United States

View Trial Details

Completed

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

NCT00625443

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Pacific Cancer Medical Center, Inc Anaheim, California, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

Davis, Posteraro and Wasser, MDs, LLP Manchester, Connecticut, United States

Florida Cancer Institute New Port Richey, Florida, United States

View Trial Details

Completed

Study of Immune Thrombocytopenia Pathogenesis:

NCT02042560

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: CHU de Besançon Besançon, France

CHU de Dijon Dijon, France

CHU de METZ Metz, France

View Trial Details

Completed

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00441090

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Pacific Cancer Medical Center, Inc Anaheim, California, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

Bay Area Cancer Research Group, LLC Concord, California, United States

Pacific Coast Hematology/Oncology Medical Group Inc. Fountain Valley, California, United States

View all 25 locations

View Trial Details

Completed

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

NCT01976104

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +3 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Little Rock, Arkansas, United States

Coronado, California, United States

View all 120 locations

View Trial Details

Completed

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

NCT01972529

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +3 more
Locations: Lancaster, California, United States

Long Beach, California, United States

Los Angeles, California, United States

Sacramento, California, United States

View all 109 locations

View Trial Details

Completed

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

NCT02521441

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Completed

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

NCT01355289

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +2 more
Locations: Health Care Consultants Los Angeles, California, United States

Metropolitan Research Fairfax, Virginia, United States

View Trial Details

Completed

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

NCT01438840

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Adelaide, Australia

Bedford Park, Australia

Antwerp, Belgium

Plovdiv, Bulgaria

View all 25 locations

View Trial Details

Completed

Efficacy of Sialic Acid GNE Related Thrombocytopenia

NCT02845609

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +5 more
Locations: Not specified

View Trial Details